Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind Study on the Safety and Efficacy of Infliximab in Palmoplantar Psoriasis

NCT00629772 is registered in ClinicalTrials.gov with Innovaderm Research Inc. as lead sponsor.

NCT NCT00629772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00629772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind Study on the Safety and Efficacy of Infliximab in Palmoplantar Psoriasis
Lead sponsor
Innovaderm Research Inc.
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2007
Completion date
July 31, 2009
Enrollment
24 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

palmoplantar psoriasis